Tim Lautenschlaeger MD
Assistant Professor, Radiation Oncology, Indiana University
Join to View Full Profile
535 Barnhill Dr# ROUTE041Indianapolis, IN 46202
Phone+1 317-944-2524
Fax+1 317-944-2486
Dr. Lautenschlaeger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University HospitalResidency, Radiation Oncology, 2011 - 2015- Ohio State University HospitalInternship, Transitional Year, 2010 - 2011
Philipps University of Marburg Faculty of MedicineClass of 2006
Certifications & Licensure
IN State Medical License 2015 - 2027
OH State Medical License 2010 - 2015
American Board of Radiology Radiation Oncology
Clinical Trials
- Biomarker Identification for Bladder Cancer Patients Start of enrollment: 2014 Jan 21
- Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy Start of enrollment: 2012 Oct 04
- Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung Start of enrollment: 2017 Oct 20
Publications & Presentations
PubMed
- In the Era of Neoadjuvant Chemoimmunotherapy, is There a Role for Radiation Intensification Therapy in Patients With Stage III (N2) Non-Small Cell Lung Cancer (NSCLC) ...Meagan Miller, Tim Lautenschlaeger, Thomas Birdas, Nasser Hanna, Greg Durm
Clinical Lung Cancer. 2025-11-01 - 3 citationsDiCE: differential centrality-ensemble analysis based on gene expression profiles and protein-protein interaction network.Elnaz Pashaei, Sheng Liu, Kailing Li, Yong Zang, Lei Yang
Nucleic Acids Research. 2025-07-08 - 1 citationsDiCE: differential centrality-ensemble analysis based on gene expression profiles and protein-protein interaction network.Elnaz Pashaei, Sheng Liu, Kailing Li, Yong Zang, Lei Yang
Biorxiv. 2025-03-17
Journal Articles
- TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas - a Pilot Prospective StudyTim Lautenschlaeger, MD, Clinical Cancer Research
Press Mentions
MicroRNA-31 Might Predict Lung-Cancer SpreadSeptember 24th, 2013
Grant Support
- Urine based circulating tumor DNA analysisINDIANA UNIVERSITY INDIANAPOLIS2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
